# DAPSONE
> **ANDA213414** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2026-06-25
## Drug
- **FDA Application Number:** ANDA213414
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPSONE
- **Generic name:** DAPSONE
- **Active ingredients:** DAPSONE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2026-06-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213414)
---
*MORVS · CC0 1.0*